Blood group chimerism

Current Opinion in Hematology

Volumn 13, Issue 6, 2006, Pages 484-489

  Drexler, Camilla ^a   Wagner, Thomas ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Blood chimerism; Chimera; Microchimerism; Mixed field in blood grouping; Molecular blood group chimerism

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; BLOOD GROUP; BLOOD GROUP TYPING; CHIMERA; DIAGNOSIS, MEASUREMENT AND ANALYSIS; FETUS BLOOD; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; MATERNAL BLOOD; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; RESEARCH; REVIEW; STEM CELL TRANSPLANTATION;

BLOOD GROUPING AND CROSSMATCHING; CHIMERISM; HUMANS; IMMUNE TOLERANCE; MOLECULAR DIAGNOSTIC TECHNIQUES; STEM CELL TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750223517     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/01.moh.0000245690.54956.f3     Document Type: Review

References (103)

1. Anderson D, Billingham RE, Lampkin GH, Medawar PB. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 1951; 5:379-397.
2. Ford CE. Mosaics and Chimaeras. Br Med Bull 1969; 25:104-109.
3. Race RR, Sanger R. Blood groups in twins and chimeras. In: Race RR, Sanger R, editors. Blood groups in man. Oxford, UK: Blackwell Scientific Productions; 1975. pp. 511-546.
4. Tippett P. Blood group chimeras. Vox Sang 1983; 44:333-359.
5. Bird GWG. Mixtures, mosaics, and modifications. In: Greenwalt TJ, Steane EA, editors. CRC handbook series in clinical laboratory science Section D: Blood banking, vol. 1. Cleveland, OH: CRC Press; 1977. pp. 475-487.
6. Bourthoumieu S, Yardin C, Terro F, et al. Monozygotic twins concordant for blood karyotype, but phenotypically discordant: a case of 'mosaic chimerism'. Am J Med Genet A 2005; 135:190-194. In this case report blood chimerism between monozygotic twins is presented, showing one twin being a mosaic with mental deficiency and anomalies in the phenotype, and the second twin, otherwise of unremarkable appearance, having the mosaic cells only in peripheral leukocytes.
7. Daniels G.Human blood groups. Oxford: Blackwell Science; 1995:; 684-692.
8. Owen RD. Immunogenic consequences of vascular anastomoses between bovine twins. Science 1945; 102:400-401.
9. Yu N, Kruskall MS, Yunis JJ, et al. Disputed maternity leading to identification of tetragametic chimerism. N Engl J Med 2002; 346:1545-1552.
10. Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings. Biol Blood Marrow Transplant 2001; 7:473-485.
11. Strain L, Dean JCS, Hamilton MPR, Bonthron DT. A true hermaphrodite chimera resulting from embryo amalgamation after in vitro fertilization. N Engl J Med 1998; 338:166-169.
12. Giltay JC, Brunt T, Beemer FA, et al. Polymorphic detection of a parthenogenetic maternal and double paternal contribution to a 46,XX/46,XY hermaphodite. Am J Hum Genet 1998; 62:937-940.
13. Wiley JE, Madigan M, Christie JD, Smith AW. Dispermic chimerism with two abnormal cell lines, 47, XY+21 and 47XX+12. Am J Med Gen 2002; 107:64-66.
14. Lucon DR, Zanchetta LM, Cavalcanti DP. Chimerism 47,XY+21/46,XX in a female infant with anencephaly and other congenital defects. Genet Mol Biol 2006; 29:36-37.
15. Moores PP, Watkins WM, Greenwell P, et al. Zulu XX/XX dispermic chimaera from Natal with two populations of red blood cells and patchy skin pigmentation. Vox Sang 1988; 54:52-56.
16. Gartler SM, Waxman SH, Giblett E. An XX/XY human hermaphrodite resulting from double fertilization. Proc Natl Acad Sci U S A 1962; 48:332-335.
17. Repas-Humpe, Humpe A, Lynen R, Glock B, et al. A dispermic chimerism in a 2-year-old Caucasian boy. Ann Hematol 1999; 78:431-434.
18. Glock B, Wagner T, Dauber EM. Investigations of chimerism in a healthy, adult female by means of minisatellite and microsatellite typing. International Congress Series 2003; 1239:561-563.
19. Sun CF, Chen DP, Tseng CP, et al. Identification of a novel A1v-O1v hybrid allele with G829A mutation in a chimeric individual of AelBel phenotype. Transfusion 2006; 46:780-789. Here, an unusual chimerism in a phenotypically normal proposita with a de-novo recombination in the maternal germ line during meiosis is described, showing a decrease in A-transferase activity.
20. Drexler C, Glock B, Vadon M, et al. Tetragametic chimerism detected in a healthy woman with mixed-field agglutination reactions in ABO blood grouping. Transfusion 2005; 45:698-703. A healthy female chimera was only identified as being derived from double parental contribution by the use of retired marker systems.
21. Schmorl CG. Pathologisch-anatomische Untersuchungen über Puerperal-Eklampsie [Pathological-anatomical explorations on puerperal eclampsia]. Leipzig: Verlag F.C.W. Vogel; 1893.
22. Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1969; 1:1119-1122.
23. Schröder J. Transplacental passage of blood cells. J Med Genet 1975; 12:230-242.
24. Herzenberg LA, Bianchi DW, Schröder J, et al. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A 1979; 76:1453-1455.
25. Lo YMD, Lo ESF, Watson N, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996; 88:4390-4395.
26. Bianchi DW, Farina A, Weber W, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001; 184:703-706.
27. Campagnoli C, Fisk N, Overton T, et al. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood 2000; 95:1967-1972.
28. McEwan A. Harvesting fetal cells from the maternal circulation. Fet Mat Med Rev 2005; 16:151-177. This is a comprehensive review on progresses in noninvasive prenatal diagnosis with special respect to cell enrichment and cell analysis.
29. Ariga H, Ohto H, Busch P, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41:1524-1530.
30. Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am J Med Genet 2000; 91:22-28.
31. Rujiwetpongstorn J, Tongsong T, Wanapirak C, et al. Feto-maternal hemorrhage after cordocentesis at Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai 2005; 88:145-149. More than 50% of cordocenteses are associated with a significant feto-maternal hemorrhage of over 0.25%; testings were made by Kleihauer Bethke test.
32. Khosrotehrani K, Johnson KL, Lau J, et al. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003; 48:3237-3241.
33. Holzgreve W, Ghezzi F, Di Naro E, et al. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998; 91:669-672.
34. Lo YMD, Leung TN, Tein MSC, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45:184-188.
35. Zhou Y, Damsky CH, Chiu K, et al. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91:950-960.
36. Sugito Y, Sekizawa A, Farina A, et al. Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin Chem 2003; 49:1667-1669.
37. Leung TN, Zhang J, Lau TK, et al. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998; 352:1904-1905.
38. Hsieh TT, Pao CC, Hor JJ, Kao SM. Presence of fetal cells in maternal circulation after delivery. Hum Genet 1993; 92:204-205.
39. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93:705-708.
40. Maloney S, Smith A, Furst DE, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104:41-47.
41. Lambert NC, Pang JM, Yan Z, et al. Male microchimerism in women with systemic sclerosis and healthy women who never gave birth to a son. Ann Rheum Dis 2005; 64:845-848. Male microchimerism in a childless woman is thought to have several possible sources: a previous pregnancy which was not carried to term, a blood cell transfer in utero from a male twin to the woman herself with the loss of this twin at an early stage of gestation, a transfer of persisting blood cells in the maternal circulation from an older brother and from sexual intercourse alone.
42. Nelson JL. Microchimerism: incidental byproduct of pregnancy or active participant in human health? Trends Mol Med 2002; 8:109-113.
43. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338:1186-1191.
44. Jimenez SA, Artlett CM. Microchimerism and systemic sclerosis. Curr Opin Rheumatol 2005; 17:86-90. In this paper, the possible role of microchimeric cells in the pathogenesis of systemic sclerosis is reviewed.
45. Invernizzi P, De Andreis C, Sirchia SM, et al. Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol 2000; 122:418-422.
46. Klintschar M, Schwaiger P, Mannweiler S, et al. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2001; 86:2494-2498.
47. Walsh JP, Bremner AP, Bulsara MK, et al. Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab 2005; 90:5309-5312. In a large Australian study including 1045 females a role of microchimerism in the pathogenesis of autoimmune thyroid disease was not seen.
48. Mosca M, Curcio M, Lapi S, et al. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis 2003; 62:651-654.
49. Toda I, Kuwana M, Tsubota K, Kawakami Y. Lack of evidence of an increased microchimerism in the circulation of patients with Sjögren's syndrome. Ann Rheum Dis 2001; 60:248-253.
50. Reed AM, McNallan K, Wettstein P, et al. Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis? J Immunol 2004; 172:5041-5046.
51. Vabres P, Bonneau D. Childhood dermatosis due to microchimerism. Dermatology 2005; 211:388-389. This is the first case of fraternal microchimerism with very unusual cutaneous features reminiscent of chronic GvHD.
52. Stevens AM, Hermes HM, Lambert NC, et al. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome congenital heart block. Rheumatology (Oxford) 2005; 44:187-191. A possible association between microchimerism and neonatal lupus syndrome-congenital heart block was suggested after the study of two families.
53. Kowalzick L, Artlett CM, Thoss K, et al. Chronic graft-versus-host- disease-like dermopathy in a child with CD4+ cell microchimerism. Dermatology 2005; 210:68-71. In a patient with clinical features of lupus erythematodes and scleroderma whilst showing a lichen ruber pattern blood CD4+ lymphocytes of maternal origin were found. The presence of maternal cells in inflamed muscle tissue strongly indicated the maternal microchimerism as being the reason for the pathological alterations.
54. Scaletti C, Vultaggio A, Bonifacio S, et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002; 46:445-450.
55. Nelson JL. Microchimerism in human health and disease. Autoimmunity 2003; 36:5-9.
56. Lambert NC, Evans PC, Hashizumi TL, et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol 2000; 164:5545-5548.
57. Lambert NC, Stevens AM, Tylee TS, et al. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann N Y Acad Sci 2001; 945:164-171.
58. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42:1079-1085.
59. Van der Schoot CE, Soussan AA, Koelewijn J, et al. Noninvasive antenatal RHD typing. Transfus Clin Biol 2006; 13:53-57. Noninvasive prenatal RhD typing is introduced as an accurate, reliable means for screening purposes which may significantly reduce unnecessary administration of antenatal anti-D.
60. Nelson JN, Hughes KA, Smith AG, et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329:466-471.
61. Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol 2004; 99:1523-1526.
62. Klein HG, Anstee DJ. Rh D immunization by transfusion. In: Mollison's blood transfusion in clinical medicine. 11th ed. Oxford: Blackwell; 2005. pp. 183-194.
63. Bader P, Kreyenberg H, Hoelle A, et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for preemptive immunotherapy? J Clin Oncol 2004; 22:1696-1705.
64. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001; 14:417-424.
65. Brouha PC, Ildstad ST. Mixed allogeneic chimerism: past, present and prospects for the future. Transplantation 2001; 72 (8 Suppl):S36-S42.
66. Alimoghaddam K, Ghaffari H, Foroughi F, et al. Effects of chimerism on graftversus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran. Arch Iran Med 2006; 9:99-103. In this work, survival and relapse rates of patients with mixed and complete chimerism were examined. No significant difference was found, possibly because the percentage of mixed chimerism in patients was close to complete chimerism.
67. Auffermann-Gretzinger S, Lossos IS, Vayntrub TA, et al. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood 2002; 99:1442-1448.
68. Aguila HL, Weissman IL. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 1996; 87:1225-1231.
69. Westerhuis G, Maas WGE, Willemze R, et al. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 2005; 106:2215-2220. In an animal experimental study on mice a significant influence of natural killer cells for the establishment of chimerism, immune tolerance and graft survival was shown, indicating that natural killer depletion may enhance graftment.
70. Boeck S, Hamann M, Pihusch V, et al. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplant 2006; 37:57-64. Dendritic and T-cell chimerism after allogeneic hematopoietic cell transplantation was evaluated, finding a fast and stable complete donor chimerism in myeloic and plasma cell dendritic cells as well as in T cells.
71. Jaksch M, Uzunel M, Remberger M, et al. Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV. Clin Transplant 2005; 19:346-349. A significantly higher risk of developing acute GVHD II-IV was found in patients with complete donor CD4+ T-cell chimerism day 7 after stem cell transplant or an increase in at least 50% between day 7 and 10, suggesting that an early monitoring of T-cell chimerism may be of use for the identification of patients at risk for developing acute GVHD after stem cell transplant.
72. Galimberti S, Benedetti E, Morabito F, et al. Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting. Transpl Immunol 2005; 15:173-177. The authors state that the lack of a final conclusion with respect to the prognostic role of microchimerism was due to short follow-up or the small number of patients included in the study.
73. Wenk RE, Chiafari PA. DNA typing of recipient blood after massive transfusion. Transfusion 1997; 37:1108-1110.
74. Naiman JL, Punnett HH, Lischner HW, et al. Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis. N Engl J Med 1969; 281:697-701.
75. Viëtor HE, Hallensleben E, van Bree SP, et al. Survival of donor cells 25 years after intrauterine transfusion. Blood 2000; 95:2709-2714.
76. Dinsmore RE, Straus DJ, Pollack MS, et al. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing. Blood 1980; 55:831-834.
77. Lee TH, Paglieroni T, Ohto H, et al. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93:3127-3139.
78. Xie HY, Huang DS, Jia CK, Zheng SS. Infusion of nonmyeloablative bone marrow alleviates acute rejection reaction in liver allotransplantation. J Zhejiang Univ Sci B 2005; 6:1188-1194. In a rat model it was shown that low-level chimerism in peripheral blood can be derived after transplantation of vascularized tibia bone graft as well as high level chimerism in spleen, liver and thymus gland of rats.
79. Starzl TE. Chimerism and tolerance in transplantation. Proc Nat Acad Sci U S A 2004; 101 (Suppl 2):14607-14614.
80. Delis S, Ciancio G, Burke GW 3rd, et al. Donor bone marrow transplantation: chimerism and tolerance. Transpl Immunol 2004; 13:105-115.
81. Williams CA, Wallace MR, Drury KC, et al. Blood lymphocyte chimerism associated with IVF and monochorionic dizygous twinning: case report. Hum Reprod 2004; 19:2816-2821.
82. Souter VL, Kapur RP, Nyholt DR, et al. A report of dizygous monochorionic twins. N Engl J Med 2003; 349:154-158.
83. Aoki R, Honma Y, Yada Y, et al. Blood chimerism in monochorionic twins conceived by induced ovulation: case report. Hum Reprod 2006; 21:735-737. This is a case report on blood group chimerism following induced ovulation with clomiphene. Possible explanations for underlying mechanisms for monochorionic placentation in dizygotic twins are discussed.
84. Miura K, Niikawa N. Do monochorionic dizygotic twins increase after pregnancy by assisted reproductive technology? J Hum Genet 2005; 50:1-6. Six cases of assisted reproductive technology associated with microchimerism are reviewed.
85. Führer M, Gerusel-Bleck M, Konstantopoulos N, et al. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal makers after stem cell transplantation in children. Int J Mol Med 2005; 15:291-297. In this work, the appliance of FISH on native and thawed smears as routine follow-up after aSCT and aBMT was proven feasible.
86. Garratty G, Arndt PA. Applications of flow cytofluorometry to red blood cell immunology. Cytometry (Communications in Clinical Cytometry) 1999; 38:259-267.
87. Schaap N, Schattenberg A, Bar B, et al. Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion. Br J Haematol 2000; 108:116-125.
88. Anan K, Suzuki H, Iwasaki M, Kobayashi K. Genomic analysis of ABO chimeras and mosaics using hematopoietic colony-derived DNA. Transfusion 1999; 39:1247-1255.
89. Reed WF, Lee TL, Trachtenberg E, et al. Detection of microchimerism by PCR is a function of amplification strategy. Transfusion 2001; 41:39-44.
90. Kamel AM, Mossallam GI, Mahmoud HK, et al. Variable number tandem repeat polymorphism as a tool of chimerism detection in allogeneic stem cell transplantation. J Egypt Natl Cancer Inst 2002; 14:275-287.
91. Schwartz DWM, Glock B, Jungl EM, Mayr WR. Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms. Vox Sang 1995; 68:139-143.
92. Scharf SJ, Smith AG, Hansen JA, et al. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85:1954-1963.
93. Oliver DH, Thompson RE, Griffin CA, Eshleman JR. Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J Mol Diagn 2000; 2:202-208.
94. Alizadeh M, Bernard M, Danic B, et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002; 99:4618-4625.
95. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350:485-487.
96. Galbiati S, Smid M, Gambini D, et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005; 117:243-248. In this study, fetal DNA was detected in all pregnant women from the sixth week throughout the whole pregnancy, showing a statistically significant correlation with increasing gestational age.
97. Cremonesi L, Galbiati S, Foglieni B, et al. Feasibility study for a microchip-based approach for nonivasive prenatal diagnosis of genetic diseases. Ann N Y Acad Sci 2004; 1022:105-112.
98. Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 2002; 48:1647-1653.
99. Tsui NBY, Chim SSC, Chiu RWK, et al. Systematic micro-array based identification of placental mRNA in maternal plasma: towards noninvasive prenatal gene expression profiling. J Med Genet 2004; 41:461-467.
100. Van der Hart M, van Loghem JJ. Blood group chimerism. Vox Sang 1967; 12:161-172.
101. Tippett P, Ellis N, de Silva M, Wallace M. Continuing investigation of proportion of cell lines in a twin chimera [abstract]. Transfusion Med 1992; 2 (Suppl 1):44.
102. van Dijk BA, Boomsma DI, de Man AJM. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996; 61:264-268.
103. Boklage CE. Embryogenesis of chimeras, twins and anterior midline asymmetries. Hum Reprod 2006; 21:579-591. This review outlines natural chimerism, highlighting pathogenesis of chimeras as a possibility to gain insights into human embryogenesis.